BIOMARKERS FOR IMMUNE CHECKPOINT INHIBITORS TREATMENT

The present invention relates to methods for determining or predicting if a patient having a predetermined disease, for example cancer, in particular metastatic urothelial cancer, is responsive, or will respond to a treatment based on immune checkpoint inhibitor. The present invention also relates t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HOSSEINIAN EHRENSBERGER, SAHAR, CIARLONI, LAURA, WOSIKA, VICTORIA, MONNIER-BENOIT, SYLVAIN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to methods for determining or predicting if a patient having a predetermined disease, for example cancer, in particular metastatic urothelial cancer, is responsive, or will respond to a treatment based on immune checkpoint inhibitor. The present invention also relates to computer-implemented methods for implementing said methods. La présente invention concerne des procédés pour déterminer ou prédire si un patient ayant une maladie prédéterminée, par exemple le cancer, en particulier le cancer urothélial métastatique, est sensible, ou répondra à un traitement basé sur un inhibiteur de points de contrôle immunitaires. La présente invention concerne également des procédés mis en oeuvre par ordinateur pour réaliser lesdits procédés.